{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T06:29:23Z","timestamp":1792736963134,"version":"4.5.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"23","license":[{"start":{"date-parts":[[2008,6,1]],"date-time":"2008-06-01T00:00:00Z","timestamp":1212278400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,6,1]],"date-time":"2008-06-01T00:00:00Z","timestamp":1212278400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2008,6]]},"DOI":"10.1016\/j.vaccine.2008.03.045","type":"journal-article","created":{"date-parts":[[2008,4,11]],"date-time":"2008-04-11T15:26:46Z","timestamp":1207927606000},"page":"2930-2934","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":85,"title":["Plant-expressed HA as a seasonal influenza vaccine candidate"],"prefix":"10.1016","volume":"26","author":[{"given":"Yoko","family":"Shoji","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica A.","family":"Chichester","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Bi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantin","family":"Musiychuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"de la Rosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Goldschmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"April","family":"Horsey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Ugulava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gene A.","family":"Palmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vadim","family":"Mett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vidadi","family":"Yusibov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"27","key":"10.1016\/j.vaccine.2008.03.045_bib1","doi-asserted-by":"crossref","first-page":"5086","DOI":"10.1016\/j.vaccine.2007.03.046","article-title":"The annual impact of seasonal influenza in the US: measuring disease burden and costs","volume":"25","author":"Molinari","year":"2007","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.vaccine.2008.03.045_bib2","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1001\/jama.292.11.1333","article-title":"Influenza-associated hospitalizations in the United States","volume":"292","author":"Thompson","year":"2004","journal-title":"Jama"},{"key":"10.1016\/j.vaccine.2008.03.045_bib3","unstructured":"Kamps BS, Hoffmann C, Preiser W. Influenza report 2006 [cited; Available from: http:\/\/w.influenzareport.com\/]."},{"key":"10.1016\/j.vaccine.2008.03.045_bib4","first-page":"1533","article-title":"Orthomyxoviruses","volume":"vol. 1","author":"Wright","year":"2001"},{"key":"10.1016\/j.vaccine.2008.03.045_bib5","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1146\/annurev.biochem.69.1.531","article-title":"Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin","volume":"69","author":"Skehel","year":"2000","journal-title":"Annu Rev Biochem"},{"issue":"38","key":"10.1016\/j.vaccine.2008.03.045_bib6","doi-asserted-by":"crossref","first-page":"4678","DOI":"10.1016\/j.vaccine.2005.04.039","article-title":"Development of cell culture (MDCK) live cold-adapted (CA) attenuated influenza vaccine","volume":"23","author":"Ghendon","year":"2005","journal-title":"Vaccine"},{"issue":"32","key":"10.1016\/j.vaccine.2008.03.045_bib7","doi-asserted-by":"crossref","first-page":"6028","DOI":"10.1016\/j.vaccine.2007.05.013","article-title":"Cell culture (Vero) derived whole virus (H5N1) vaccine based on wild-type virus strain induces cross-protective immune responses","volume":"25","author":"Kistner","year":"2007","journal-title":"Vaccine"},{"issue":"17\u201319","key":"10.1016\/j.vaccine.2008.03.045_bib8","doi-asserted-by":"crossref","first-page":"2716","DOI":"10.1016\/S0264-410X(00)00508-9","article-title":"The human cell line PER.C6 provides a new manufacturing system for the production of influenza vaccines","volume":"19","author":"Pau","year":"2001","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2008.03.045_bib9","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1057\/palgrave.jphp.3200008","article-title":"Preparing for pandemic vaccination: an international policy agenda for vaccine development","volume":"26","author":"Fedson","year":"2005","journal-title":"J Pub Health Policy"},{"key":"10.1016\/j.vaccine.2008.03.045_bib10","article-title":"Vaccination of mice with recombinant baculovirus expressing spike or nucleocapsid protein of SARS-like coronavirus generates humoral and cellular immune responses","author":"Bai","year":"2007","journal-title":"Mol Immunol"},{"issue":"9","key":"10.1016\/j.vaccine.2008.03.045_bib11","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1086\/503050","article-title":"Dose-related safety and immunogenicity of a trivalent baculovirus-expressed influenza-virus hemagglutinin vaccine in elderly adults","volume":"193","author":"Treanor","year":"2006","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2008.03.045_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2007.09.006","article-title":"Large-scale manufacture and use of recombinant VP2 vaccine against infectious bursal disease in chickens","author":"Rong","year":"2007","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2008.03.045_bib13","doi-asserted-by":"crossref","first-page":"3598","DOI":"10.1128\/IAI.73.6.3598-3608.2005","article-title":"Human immune response to a plague vaccine comprising recombinant F1 and V antigens","volume":"73","author":"Williamson","year":"2005","journal-title":"Infect Immun"},{"issue":"15","key":"10.1016\/j.vaccine.2008.03.045_bib14","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1016\/j.vaccine.2004.11.021","article-title":"Plant based HIV-1 vaccine candidate: Tat protein produced in spinach","volume":"23","author":"Karasev","year":"2005","journal-title":"Vaccine"},{"issue":"15","key":"10.1016\/j.vaccine.2008.03.045_bib15","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1016\/j.vaccine.2004.11.018","article-title":"The development of a plant-based vaccine for measles","volume":"23","author":"Webster","year":"2005","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.vaccine.2008.03.045_bib16","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/sj.embor.7400470","article-title":"Molecular farming for new drugs and vaccines. Current perspectives on the production of pharmaceuticals in transgenic plants","volume":"6","author":"Ma","year":"2005","journal-title":"EMBO Rep"},{"issue":"5\u20136","key":"10.1016\/j.vaccine.2008.03.045_bib17","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S0020-7519(03)00052-3","article-title":"Plant-based vaccines","volume":"33","author":"Streatfield","year":"2003","journal-title":"Int J Parasitol"},{"issue":"1","key":"10.1016\/j.vaccine.2008.03.045_bib18","article-title":"A launch vector for the production of vaccine antigens in plants","volume":"1","author":"Musiychuk","year":"2007","journal-title":"Influenza Other Resp Virus"},{"issue":"16","key":"10.1016\/j.vaccine.2008.03.045_bib19","doi-asserted-by":"crossref","first-page":"3111","DOI":"10.1016\/j.vaccine.2007.01.068","article-title":"Immunogenicity of a subunit vaccine against Bacillus anthracis","volume":"25","author":"Chichester","year":"2007","journal-title":"Vaccine"},{"issue":"16","key":"10.1016\/j.vaccine.2008.03.045_bib20","doi-asserted-by":"crossref","first-page":"3014","DOI":"10.1016\/j.vaccine.2007.01.017","article-title":"A plant-produced plague vaccine candidate confers protection to monkeys","volume":"25","author":"Mett","year":"2007","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2008.03.045_bib21","first-page":"223","article-title":"A single-radial-immunodiffusion technique for the assay of influenza haemagglutinin antigen. Proposals for an assay method for the haemagglutinin content of influenza vaccines","volume":"52","author":"Schild","year":"1975","journal-title":"Bull World Health Organ"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2008.03.045_bib22","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jim.2005.11.015","article-title":"Different response requirements for IFNgamma production in ELISPOT assays by CD4+ T cells from mice early and late after immunization","volume":"309","author":"Chichester","year":"2006","journal-title":"J Immunol Methods"},{"issue":"4","key":"10.1016\/j.vaccine.2008.03.045_bib23","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1128\/JCM.37.4.937-943.1999","article-title":"Detection of antibody to avian influenza A (H5N1) virus in human serum by using a combination of serologic assays","volume":"37","author":"Rowe","year":"1999","journal-title":"J Clin Microbiol"},{"issue":"1","key":"10.1016\/j.vaccine.2008.03.045_bib24","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1365-3083.2005.01633.x","article-title":"Whole influenza virus vaccine is more immunogenic than split influenza virus vaccine and induces primarily an IgG2a response in BALB\/c mice","volume":"62","author":"Hovden","year":"2005","journal-title":"Scand J Immunol"},{"issue":"3","key":"10.1016\/j.vaccine.2008.03.045_bib25","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/S0264-410X(96)00183-1","article-title":"Adjuvants\u2014a classification and review of their modes of action","volume":"15","author":"Cox","year":"1997","journal-title":"Vaccine"},{"issue":"9","key":"10.1016\/j.vaccine.2008.03.045_bib26","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1128\/CVI.00156-06","article-title":"Distinct contributions of vaccine-induced immunoglobulin G1 (IgG1) and IgG2a antibodies to protective immunity against influenza","volume":"13","author":"Huber","year":"2006","journal-title":"Clin Vaccine Immunol"},{"issue":"4","key":"10.1016\/j.vaccine.2008.03.045_bib27","first-page":"767","article-title":"The role of serum haemagglutination-inhibiting antibody in protection against challenge infection with influenza A2 and B viruses","volume":"70","author":"Hobson","year":"1972","journal-title":"J Hyg"},{"issue":"9","key":"10.1016\/j.vaccine.2008.03.045_bib28","doi-asserted-by":"crossref","first-page":"3271","DOI":"10.1021\/jf060169h","article-title":"Quillaja saponin can modulate ovalbumin-induced IgE allergic responses through regulation of Th1\/Th2 balance in a murine model","volume":"54","author":"Katayama","year":"2006","journal-title":"J Agric Food Chem"},{"issue":"17","key":"10.1016\/j.vaccine.2008.03.045_bib29","doi-asserted-by":"crossref","first-page":"3263","DOI":"10.1016\/j.vaccine.2007.01.073","article-title":"Humoral and cell-mediated immune responses of humans to inactivated influenza vaccine with or without QS21 adjuvant","volume":"25","author":"Mbawuike","year":"2007","journal-title":"Vaccine"},{"issue":"14","key":"10.1016\/j.vaccine.2008.03.045_bib30","doi-asserted-by":"crossref","first-page":"4170","DOI":"10.1158\/1078-0432.CCR-06-2949","article-title":"Pilot study of a heptavalent vaccine-keyhole limpet hemocyanin conjugate plus QS21 in patients with epithelial ovarian, fallopian tube, or peritoneal cancer","volume":"13","author":"Sabbatini","year":"2007","journal-title":"Clin Cancer Res"},{"issue":"5-6","key":"10.1016\/j.vaccine.2008.03.045_bib31","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0020-7519(03)00053-5","article-title":"Recent advances in veterinary vaccine adjuvants","volume":"33","author":"Singh","year":"2003","journal-title":"Int J Parasitol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X08003691?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X08003691?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:15:44Z","timestamp":1759400144000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X08003691"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,6]]},"references-count":31,"journal-issue":{"issue":"23","published-print":{"date-parts":[[2008,6]]}},"alternative-id":["S0264410X08003691"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2008.03.045","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2008,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Plant-expressed HA as a seasonal influenza vaccine candidate","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2008.03.045","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}